CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
26.05
0.35 (1.36%)
At close: Aug 18, 2025, 2:37 PM
CG Oncology Common stock Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
PE Ratio | n/a | -13.54 | -14.62 | -31.04 | -27.96 | -42.07 | -38.42 | -50.73 | -53.32 | -71.45 | -73.79 |
PEG Ratio | n/a | 1.66 | -0.23 | -4.35 | -2.33 | 1.74 | -2.15 | -0.78 | -1.73 | n/a | n/a |
PS Ratio | n/a | 35.88K | 4.08K | 58.91K | 19.05K | 5.39K | 2.48M | 275.21K | n/a | 12.77K | n/a |
PB Ratio | 2.96 | 2.65 | 2.53 | 4.72 | 3.83 | 5.01 | 13.40 | -22.93 | n/a | 19.79 | 19.79 |
P/FCF Ratio | -70.85 | -63.7 | -89.07 | -159.15 | -131.04 | -109.5 | -154.22 | -228.49 | -229.51 | -310.15 | -362.75 |
P/OCF Ratio | -70.89 | -63.73 | -89.97 | -159.14 | -131.15 | -109.55 | -154.22 | -228.37 | -229.64 | -310.15 | -362.7 |
OCF/S Ratio | n/a | -563.02 | -45.31 | -370.21 | -145.23 | -49.17 | -16.06K | -1.21K | n/a | -41.16 | n/a |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | n/a | n/a | 0.13 |
Quick Ratio | 22.15 | 30.97 | 35.30 | 35.32 | 47.57 | 57.95 | 13.62 | 17.92 | n/a | n/a | 9.54 |
Current Ratio | 22.15 | 30.97 | 35.30 | 35.32 | 47.57 | 57.95 | 13.62 | 17.92 | n/a | n/a | 9.54 |
Asset Turnover | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | n/a | -0.05 | -0.04 | -0.04 | -0.03 | -0.03 | -0.09 | 0.11 | n/a | -0.07 | -0.07 |
Return on Assets | n/a | -0.05 | -0.04 | -0.04 | -0.03 | -0.03 | -0.08 | -0.06 | n/a | n/a | -0.06 |
Return on Invested Capital | -0.07 | -0.06 | -0.05 | -0.05 | -0.05 | -0.04 | -0.1 | -0.07 | n/a | n/a | -0.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 1.00 | 1.00 | 1.00 | 1.00 | 0.99 | -3 | 1.00 | n/a | -39.42 | n/a |
Net Profit Margin | n/a | -662.54 | -69.73 | -474.53 | -170.29 | -32.01 | -16.12K | -1.36K | n/a | -44.68 | n/a |
Pretax Profit Margin | n/a | -662.54 | -69.73 | -474.53 | -170.29 | -32.01 | -16.12K | -1.36K | n/a | -44.68 | n/a |
Operating Profit Margin | n/a | -811.62 | -83.44 | -658.02 | -232.91 | -42.47 | -18.93K | -1.61K | n/a | -50.11 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -811.15 | -83.44 | -657.53 | -232.91 | -42.47 | -18.93K | -1.61K | n/a | -50.09 | n/a |